Next Article in Journal
Electronic Nose-Based Technique for Rapid Detection and Recognition of Moldy Apples
Previous Article in Journal
Scalable Gas Sensing, Mapping, and Path Planning via Decentralized Hilbert Maps
Erratum published on 26 July 2019, see Sensors 2019, 19(15), 3288.

Biosensors for Epilepsy Management: State-of-Art and Future Aspects

Department of Chemistry, School of Basic and Applied Sciences, Galgotias University, Greater Noida, Gautam Buddh Nagar, Uttar Pradesh 201308, India
School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India
Bio-MEMS and Microsystems Laboratory, Department of Electrical and Computer, Engineering, Florida International University, Miami, FL 33174, USA
Functional Nanomaterials, Institute for Materials Science, Kiel University, Kaiserstr 2, D-24143 Kiel, Germany
Department of Immunology and Nano-Medicine, Institute of NeuroImmune Pharmacology, Center for Personalized Nanomedicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA
School of Life Sciences, Beijing Institute of Technology, Beijing 100081, China
College of Chemistry and Materials Science, Northwest University, Xi’an 710069, Shaanxi, China
Authors to whom correspondence should be addressed.
Sensors 2019, 19(7), 1525;
Received: 11 March 2019 / Revised: 24 March 2019 / Accepted: 25 March 2019 / Published: 28 March 2019
(This article belongs to the Section Biosensors)
Epilepsy is a serious neurological disorder which affects every aspect of patients’ life, including added socio-economic burden. Unfortunately, only a few suppressive medicines are available, and a complete cure for the disease has not been found yet. Excluding the effectiveness of available therapies, the timely detection and monitoring of epilepsy are of utmost priority for early remediation and prevention. Inability to detect underlying epileptic signatures at early stage causes serious damage to the central nervous system (CNS) and irreversible detrimental variations in the organ system. Therefore, development of a multi-task solving novel smart biosensing systems is urgently required. The present review highlights advancements in state-of-art biosensing technology investigated for epilepsy diseases diagnostics and progression monitoring or both together. State of art epilepsy biosensors are composed of nano-enabled smart sensing platform integrated with micro/electronics and display. These diagnostics systems provide bio-information needed to understand disease progression and therapy optimization timely. The associated challenges related to the development of an efficient epilepsy biosensor and vision considering future prospects are also discussed in this report. This review will serve as a guide platform to scholars for understanding and planning of future research aiming to develop a smart bio-sensing system to detect and monitor epilepsy for point-of-care (PoC) applications. View Full-Text
Keywords: nanotechnology; biosensors; neurodegenerative disorder (NDD); diagnostics; analytical tools; diseases management nanotechnology; biosensors; neurodegenerative disorder (NDD); diagnostics; analytical tools; diseases management
Show Figures

Figure 1

MDPI and ACS Style

Tiwari, S.; Sharma, V.; Mujawar, M.; Mishra, Y.K.; Kaushik, A.; Ghosal, A. Biosensors for Epilepsy Management: State-of-Art and Future Aspects. Sensors 2019, 19, 1525.

AMA Style

Tiwari S, Sharma V, Mujawar M, Mishra YK, Kaushik A, Ghosal A. Biosensors for Epilepsy Management: State-of-Art and Future Aspects. Sensors. 2019; 19(7):1525.

Chicago/Turabian Style

Tiwari, Shivani, Varsha Sharma, Mubarak Mujawar, Yogendra Kumar Mishra, Ajeet Kaushik, and Anujit Ghosal. 2019. "Biosensors for Epilepsy Management: State-of-Art and Future Aspects" Sensors 19, no. 7: 1525.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop